Robbins Umeda LLP Announces an Investigation of the Acquisition of ATS Medical, Inc. by Medtronic, Inc.

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of ATS Medical, Inc. ("ATS") (NASDAQ: ATSI) in connection with their actions in causing ATS to enter into a definitive agreement with Medtronic, Inc. ("Medtronic") (NYSE: MDT). If the transaction is completed, ATS shareholders will receive $4.00 in cash for each share of ATS they own.

Robbins Umeda LLP's investigation concerns whether ATS's Board of Directors undertook a fair process to obtain fair consideration for all shareholders of ATS.

If you are a shareholder of ATS and would like more information about your rights as a shareholder, please contact attorney Lauren Levi at 800-350-6003 or by e-mail at llevi@robbinsumeda.com.

Robbins Umeda LLP is a California-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please go to http://www.robbinsumeda.com.

Ats Medical (MM) (NASDAQ:ATSI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024